Optimized strategies of ROS-based nanodynamic therapies for tumor theranostics

Yifan Di1, Ruizhu Deng1, Zhu Liu1

  • 1Department of Pharmaceutics, School of Pharmacy, Shenyang Pharmaceutical University, 103 Wenhua Road, Shenyang, Liaoning Province 110016, China.

Biomaterials
|November 23, 2023
PubMed

Insights

Reactive oxygen species (ROS)-based nanodynamic therapies (NDTs) show promise for cancer treatment. This review explores strategies to enhance ROS production, overcoming tumor microenvironment challenges for improved therapeutic efficacy.

Area of Science:

  • Oncology
  • Nanomedicine
  • Biochemistry

Background:

  • Reactive oxygen species (ROS) are critical regulators of tumor progression and biological processes.
  • ROS-based nanodynamic therapies (NDTs) offer non-invasive, tumor-specific cancer treatment with low side effects.
  • Existing NDTs face limitations due to the complex tumor microenvironment and sensitizer constraints, impacting ROS levels and therapeutic outcomes.

Purpose of the Study:

  • To comprehensively review nanodynamic potentiation strategies for enhancing ROS levels in NDTs.
  • To outline current challenges and solutions for various NDT modalities.
  • To discuss universal potentiation strategies and combination treatments based on NDTs.

Main Methods:

  • Literature review focusing on ROS-based nanodynamic therapies.
  • Analysis of current dilemmas and solutions for photodynamic, chemodynamic, and sonodynamic therapies.
  • Elaboration of NDT potentiation strategies and combination therapies.

Main Results:

  • NDTs are a rapidly developing field with diverse branches like photodynamic, chemodynamic, and sonodynamic therapies.
  • Strategies to increase ROS yield are crucial for overcoming NDT limitations.
  • Universal potentiation strategies and combination treatments offer promising avenues for NDT advancement.

Conclusions:

  • Addressing tumor microenvironment complexity and sensitizer limitations is key to improving NDT efficacy.
  • Developing strategies to potentiate ROS production is an urgent need for NDT advancement.
  • Further research and clinical translation are essential for the successful development of NDTs.